يعرض 1 - 10 نتائج من 22 نتيجة بحث عن '"hearing—drug effects"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Paediatric Oncology, ARD - Amsterdam Reproduction and Development, Pediatrics, Internal Medicine, Obstetrics & Gynecology, Pediatric surgery, CCA - Cancer biology and immunology, Amsterdam Reproduction & Development (AR&D)

    المصدر: European Journal of Cancer, 138, 212-224. ELSEVIER SCI LTD
    Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity : Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
    European Journal of Cancer, 138, 212-224. Elsevier Limited
    European Journal of Cancer, 138, 212-224. Elsevier Ltd.
    European Journal of Cancer, 138, 212-224. Pergamon
    European journal of cancer, Vol. 138 (2020) pp. 212-224
    PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Candidate gene, Pharmacogenomic Variants, Cancer survivors, CHILDREN, Anti-neoplastic drugs, VARIANTS, OCT2, Carboplatin, 0302 clinical medicine, Hearing, Risk Factors, Neoplasms, TPMT, Hearing / drug effects, Prospective Studies, Age of Onset, Child, 610 Medicine & health, PREDICTORS, media_common, Hearing Loss, Sensorineural / physiopathology, education.field_of_study, ddc:618, Thiopurine methyltransferase, biology, carboplatin [Cisplatin], Neoplasms / drug therapy, Organic Cation Transporter 2, Europe, Cisplatin: carboplatin, Cisplatin / adverse effects, 030220 oncology & carcinogenesis, Child, Preschool, Organic Cation Transporter 2 / genetics, Female, SENSITIVITY, Childhood cancer, 360 Social problems & social services, Cohort study, Drug-induced ototoxicity, medicine.medical_specialty, INDUCED HEARING-LOSS, Adolescent, Multicenter cohort study, Hearing Loss, Sensorineural, Population, Adverse drug reaction, Antineoplastic Agents, Polymorphism, Single Nucleotide, Risk Assessment, Hearing Loss, Sensorineural / chemically induced, Carboplatin / adverse effects, 03 medical and health sciences, ACYP2, Ototoxicity, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Genetic predisposition, media_common.cataloged_instance, Humans, Genetic Predisposition to Disease, CISPLATIN-INDUCED OTOTOXICITY, European union, education, Genetic Association Studies, Genetic association, Retrospective Studies, business.industry, Antineoplastic Agents / adverse effects, Infant, Newborn, Infant, Odds ratio, Guideline, medicine.disease, COMT, Pharmacogenomic Testing, 030104 developmental biology, Cross-Sectional Studies, Pharmacogenetics, biology.protein, Genetic markers, Hearing Loss, Sensorineural / genetics, Cisplatin, business

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية
  6. 6
    رسالة جامعية

    المؤلفون: Karlsson, Kjell K.

    Degree: Diss. (sammanfattning) Stockholm : Karol. inst.

  7. 7
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  8. 8
  9. 9
  10. 10
    دورية أكاديمية